CAMBRIDGE, Mass., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI), a clinical stage biotechnology company focused on...
Checkmate Pharmaceuticals, a Cambridge, MA-based clinical stage biotechnology company with a novel approach to cancer immunotherapy, completed an $85m Series C financing